Dexrabeprazole sodium is a proton pump inhibitor (PPI) used to treat acid-related disorders like GERD, peptic ulcers, and Zollinger-Ellison syndrome. It provides faster relief at lower doses than standard medications. The typical adult dosage is 10 mg once daily, often taken in the morning. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include (R)-Rabeprazole sodium. Its PubChem CID is 10786084.
Dexrabeprazole sodium
| CAS No | 171440-18-9 |
|---|---|
| Molecular Formula | C18H20N3NaO3S |
| Molecular Weight | 381.4 g/mol |
| Synonyms | sodium 2-[(R)-[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Dexrabeprazole sodium is a proton pump inhibitor (PPI) used to treat acid-related disorders like GERD, peptic ulcers, and Zollinger-Ellison syndrome. It provides faster relief at lower doses than standard medications.
The listed CAS number is 171440-18-9.
The listed molecular formula is C18H20N3NaO3S.
The listed molecular weight is 381.4 g/mol.
sodium 2-[(R)-[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]benzimidazol-1-ide.
The source lists (R)-Rabeprazole sodium.